ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

Brain tumor foundations form collaboration.

July 15, 2005

Guest Editorial: Myriad Ruling Becomes a Textbook Case Of How Not To Manage a Patent Portfolio, by Robert Cook-Deegan

June 14, 2013

Chabner Cautions Against Downsizing, Consolidation Of NCI Intramural Programs

March 3, 1995

Cancer Groups Propose Six Characteristics Of Next FDA Head.

December 19, 2008

Recompetition of $1.9 Mil. Primate Contract Approved

November 15, 1985

Cancer Groups Urge Support For Comprehensive Cancer Care Legislation.

June 29, 2007